Intuitive Surgical (ISRG) Received its Third Buy in a Row


After Cantor Fitzgerald and Piper Jaffray gave Intuitive Surgical (NASDAQ: ISRG) a Buy rating last month, the company received another Buy, this time from Citigroup. Analyst Amit Hazan maintained a Buy rating on Intuitive Surgical today and set a price target of $601. The company’s shares closed yesterday at $521.90.

According to TipRanks.com, Hazan is a 4-star analyst with an average return of 10.5% and a 57.3% success rate. Hazan covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Varian Medical Systems, and Baxter International.

Intuitive Surgical has an analyst consensus of Strong Buy, with a price target consensus of $611.22.

See today’s analyst top recommended stocks >>

Intuitive Surgical’s market cap is currently $59.6B and has a P/E ratio of 78.01. The company has a Price to Book ratio of 9.49.

Based on the recent corporate insider activity of 89 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts